{"id":3993,"date":"2023-12-22T16:53:31","date_gmt":"2023-12-22T08:53:31","guid":{"rendered":"https:\/\/www.epshk.hk\/?p=3993"},"modified":"2023-12-22T16:53:31","modified_gmt":"2023-12-22T08:53:31","slug":"the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs","status":"publish","type":"post","link":"https:\/\/www.epshk.hk\/en\/the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs\/","title":{"rendered":"The enrolment of patients has been initiated in the investigator-initiated clinical trials to which FEF Pharmaceutical Co., Ltd. provides investigational drugs"},"content":{"rendered":"<p>FEF Pharmaceutical Co., Ltd. and Kyoto University are conducting a collaborative research project aimed at developing a novel treatment for lower extremity artery disease (LEAD).<br \/>\nKyoto University has released a news release regarding the initiation of the investigator-initiated clinical trial of EIM-001 which is developed by FEF Pharmaceutical Co., Ltd.<br \/>\nPlease refer to the <a href=\"https:\/\/www.kuhp.kyoto-u.ac.jp\/press\/20231222.html\">press release of Kyoto University Hospital<\/a> for details.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>FEF Pharmaceutical Co., Ltd. and Kyoto University are conducting a collaborative research project aimed at developing a novel treatment for lower extremity artery disease (LEAD). Kyoto University has released a news release regarding the initiation of the investigator-initiated clinical trial of EIM-001 which is developed by FEF Pharmaceutical Co., Ltd. Please refer to the press [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[80],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The enrolment of patients has been initiated in the investigator-initiated clinical trials to which FEF Pharmaceutical Co., Ltd. provides investigational drugs - EPS Creative Health<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www._dmarc.epshk.hk\/en\/the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The enrolment of patients has been initiated in the investigator-initiated clinical trials to which FEF Pharmaceutical Co., Ltd. provides investigational drugs - EPS Creative Health\" \/>\n<meta property=\"og:description\" content=\"FEF Pharmaceutical Co., Ltd. and Kyoto University are conducting a collaborative research project aimed at developing a novel treatment for lower extremity artery disease (LEAD). Kyoto University has released a news release regarding the initiation of the investigator-initiated clinical trial of EIM-001 which is developed by FEF Pharmaceutical Co., Ltd. Please refer to the press [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www._dmarc.epshk.hk\/en\/the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs\/\" \/>\n<meta property=\"og:site_name\" content=\"EPS Creative Health\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-22T08:53:31+00:00\" \/>\n<meta name=\"author\" content=\"user\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"user\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www._dmarc.epshk.hk\/en\/the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs\/\",\"url\":\"https:\/\/www._dmarc.epshk.hk\/en\/the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs\/\",\"name\":\"The enrolment of patients has been initiated in the investigator-initiated clinical trials to which FEF Pharmaceutical Co., Ltd. provides investigational drugs - EPS Creative Health\",\"isPartOf\":{\"@id\":\"https:\/\/www.epshk.hk\/#website\"},\"datePublished\":\"2023-12-22T08:53:31+00:00\",\"dateModified\":\"2023-12-22T08:53:31+00:00\",\"author\":{\"@id\":\"https:\/\/www.epshk.hk\/#\/schema\/person\/761badd7283802b48aae11d0362efb06\"},\"breadcrumb\":{\"@id\":\"https:\/\/www._dmarc.epshk.hk\/en\/the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www._dmarc.epshk.hk\/en\/the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www._dmarc.epshk.hk\/en\/the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.epshk.hk\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The enrolment of patients has been initiated in the investigator-initiated clinical trials to which FEF Pharmaceutical Co., Ltd. provides investigational drugs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.epshk.hk\/#website\",\"url\":\"https:\/\/www.epshk.hk\/\",\"name\":\"EPS Creative Health\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.epshk.hk\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.epshk.hk\/#\/schema\/person\/761badd7283802b48aae11d0362efb06\",\"name\":\"user\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.epshk.hk\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff953ef664a0be706733d1bc84dbbf1d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff953ef664a0be706733d1bc84dbbf1d?s=96&d=mm&r=g\",\"caption\":\"user\"},\"url\":\"https:\/\/www.epshk.hk\/en\/author\/user\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The enrolment of patients has been initiated in the investigator-initiated clinical trials to which FEF Pharmaceutical Co., Ltd. provides investigational drugs - EPS Creative Health","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www._dmarc.epshk.hk\/en\/the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs\/","og_locale":"en_US","og_type":"article","og_title":"The enrolment of patients has been initiated in the investigator-initiated clinical trials to which FEF Pharmaceutical Co., Ltd. provides investigational drugs - EPS Creative Health","og_description":"FEF Pharmaceutical Co., Ltd. and Kyoto University are conducting a collaborative research project aimed at developing a novel treatment for lower extremity artery disease (LEAD). Kyoto University has released a news release regarding the initiation of the investigator-initiated clinical trial of EIM-001 which is developed by FEF Pharmaceutical Co., Ltd. Please refer to the press [&hellip;]","og_url":"https:\/\/www._dmarc.epshk.hk\/en\/the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs\/","og_site_name":"EPS Creative Health","article_published_time":"2023-12-22T08:53:31+00:00","author":"user","twitter_card":"summary_large_image","twitter_misc":{"Written by":"user","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www._dmarc.epshk.hk\/en\/the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs\/","url":"https:\/\/www._dmarc.epshk.hk\/en\/the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs\/","name":"The enrolment of patients has been initiated in the investigator-initiated clinical trials to which FEF Pharmaceutical Co., Ltd. provides investigational drugs - EPS Creative Health","isPartOf":{"@id":"https:\/\/www.epshk.hk\/#website"},"datePublished":"2023-12-22T08:53:31+00:00","dateModified":"2023-12-22T08:53:31+00:00","author":{"@id":"https:\/\/www.epshk.hk\/#\/schema\/person\/761badd7283802b48aae11d0362efb06"},"breadcrumb":{"@id":"https:\/\/www._dmarc.epshk.hk\/en\/the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www._dmarc.epshk.hk\/en\/the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www._dmarc.epshk.hk\/en\/the-enrolment-of-patients-has-been-initiated-in-the-investigator-initiated-clinical-trials-to-which-fef-pharmaceutical-co-ltd-provides-investigational-drugs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.epshk.hk\/en\/"},{"@type":"ListItem","position":2,"name":"The enrolment of patients has been initiated in the investigator-initiated clinical trials to which FEF Pharmaceutical Co., Ltd. provides investigational drugs"}]},{"@type":"WebSite","@id":"https:\/\/www.epshk.hk\/#website","url":"https:\/\/www.epshk.hk\/","name":"EPS Creative Health","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.epshk.hk\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.epshk.hk\/#\/schema\/person\/761badd7283802b48aae11d0362efb06","name":"user","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.epshk.hk\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff953ef664a0be706733d1bc84dbbf1d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff953ef664a0be706733d1bc84dbbf1d?s=96&d=mm&r=g","caption":"user"},"url":"https:\/\/www.epshk.hk\/en\/author\/user\/"}]}},"_links":{"self":[{"href":"https:\/\/www.epshk.hk\/en\/wp-json\/wp\/v2\/posts\/3993"}],"collection":[{"href":"https:\/\/www.epshk.hk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.epshk.hk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.epshk.hk\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.epshk.hk\/en\/wp-json\/wp\/v2\/comments?post=3993"}],"version-history":[{"count":1,"href":"https:\/\/www.epshk.hk\/en\/wp-json\/wp\/v2\/posts\/3993\/revisions"}],"predecessor-version":[{"id":3994,"href":"https:\/\/www.epshk.hk\/en\/wp-json\/wp\/v2\/posts\/3993\/revisions\/3994"}],"wp:attachment":[{"href":"https:\/\/www.epshk.hk\/en\/wp-json\/wp\/v2\/media?parent=3993"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.epshk.hk\/en\/wp-json\/wp\/v2\/categories?post=3993"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.epshk.hk\/en\/wp-json\/wp\/v2\/tags?post=3993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}